Statistical characterization of QT prolongation

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 3, 2010, Pages 543-562

  Schall, Robert ^a,b   Ring, Arne ^c,d  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b IQVIA   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Bazett; ECG; Fridericia; Heart rate correction; Mixed models; QT interval; Thorough QT study; Torsades des pointes

Indexed keywords

ANALYTIC METHOD; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; HEART RATE; HUMAN; PLACEBO EFFECT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RR INTERVAL; STATISTICAL ANALYSIS;

ARRHYTHMIAS, CARDIAC; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; ELECTROCARDIOGRAM PATTERN; HEART RATE; HUMANS; LINEAR MODELS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 77951668218     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903581978     Document Type: Article

References (16)

1. Bazett, J. C. (1920). An analysis of time relations of electrocardiograms. Heart 7:353-367.
2. Chow, S. C., Liu, J. P. (2008). Design and Analysis of Bioavailability and Bioequivalence Studies, 3rd ed. New York: CRC Press.
3. Dmitrienko, A., Smith, B. (2003). Repeated-measures models in the analysis of QT interval. Pharm. Stat. 2:175-190.
4. Fridericia, L. S. (1920). Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Teil I: Beziehung zwischen der Pulsfrequenz und der Dauer des Ventrikelelektrokardiogramms bei normalen Menschen in der Ruhe. Acta Med. Scand. 53:469-486.
5. Fridericia, L. S. (2003). The duration of systole in an electrocardiogram in normal humans and in patients with heart disease (English translation of Fridericia, 1920). Ann. Noninvasive Electrocardiol. 8:343-351.
6. International Conference on Harmonization. (2005). The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. ICH Harmonised Tripartite Guideline E14, Step 4. Available at: http://www.ich.org
7. Li, L., Desai, M., Desta, Z., Flockhart, D. (2004). QT analysis: A complex answer to a "simple" problem. Stat. Med. 23:2625-2643. (Pubitemid 39206460)
8. Malik, M., Farbom, P., Batchvarov, V., Hnatkova, K., Camm, A. J. (2002). Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval. Heart 87:220-228. (Pubitemid 34177674)
9. Patterson, S. D., Jones, B., Zariffa, N. (2005). Modeling and interpreting QTc prolongation in clinical pharmacology studies. Drug Information J. 39:437-445. (Pubitemid 41609523)
10. Ring, A. (2010). Statistical models for the heart rate correction of the QT Interval. Stat. Med. (in press). DOI: 10.1002/sim.3791
11. Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R., Levy, D. (1992). An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am. J. Cardiol. 70:797-801.
12. SAS Institute, Inc. (2004). SAS/STAT 9.1 User's Guide. Vol. 4. Cary, NC: SAS Institute, Inc.
13. Schall, R., Luus, H. G. (1993). On population and individual bioequivalence. Stat. Med. 12:1109-1124. (Pubitemid 23213960)
14. Senn, S., Julious, S. (2009). Measurement in clinical trials: A neglected issue for statisticians? Stat. Med. 28:3189-3209.
15. Shah, A., Hajian, G. (2003). A maximum likelihood approach for estimating the QT correction factor using mixed effects model. Stat. Med. 22:1901-1909. (Pubitemid 36603562)
16. Wang, Y., Pan, G., Balch, A. (2008). Bias and variance evaluation of QT interval correction methods. J. Biopharm. Stat. 18:427-450. (Pubitemid 351891684)